A more recent study on melanoma survival ratios from the Human Protein Atlas and The Cancer Genome Atlas Genomic Data Commons (GDC) showed that while low ERβ expression was associated with shortened relapse-free survival (RFS), ERα and GPER were not [23]. The gene discussed is ESR2; the disease is melanoma.